Dysregulation of mechanosensing signaling in monocytes of patients with systemic sclerosis is associated with skin inflammation
8 affiliations
- 1Inflammation and Autoimmunity Program, HSS Research Institute, Hospital for Special Surgery, New York, NY 10021
- 2Department of Microbiology and Immunology, Weill Cornell Medical College of Cornell University, New York, NY 10021
- 3Immunology and Microbial Pathogenesis Program, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY 10021
- 4Department of Medicine, Weill Cornell Medicine, New York, NY 10021
- 5David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, NY 10021
- 6ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Bordeaux 33076, France
- 7Rheumatology Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux 33000, France
- 8Department of Medicine, Division of Rheumatology and Scleroderma and Vasculitis Center, Hospital for Special Surgery, New York, NY 10021
Abstract
Systemic sclerosis (SSc) is a severe autoimmune connective tissue disease characterized by immune dysregulation and progressive fibrosis of the skin and internal organs, resulting in substantial organ dysfunction and increased mortality. Fibrosis is driven in part by infiltration of immune cells, including monocytes that become activated within fibrotic tissue. However, how the mechanical properties of fibrotic skin regulate their function remains poorly understood. Here, we demonstrate that increased stiffness activates human monocytes through mechanosensing. Reanalysis of single cell RNA sequencing datasets revealed that skin infiltrating monocytes exhibit heightened inflammatory signatures as compared to circulating counterparts, with further amplification in SSc. Using collagen-coated hydrogels modeling physiological and fibrotic stiffness, we show that increased stiffness enhances CD86 expression, and broadly upregulates inflammatory transcriptional programs in human monocytes. Mechanistically, stiffness-driven activation was associated with chromatin remodeling and epigenetic reprogramming, identifying the transcription factor Specificity Protein 1 (SP1) as a central regulator. CRISPR–Cas9-mediated disruption or pharmacologic inhibition of SP1 significantly attenuated stiffness- induced inflammatory gene expression, whereas we found no evidence for involvement of the canonical YAP/TAZ–TEAD axis, and pharmacological modulation of PIEZO1 neither reproduced nor blocked the response. Further, monocytes from patients with SSc displayed altered transcriptional trajectories and an exaggerated inflammatory response to high stiffness, accompanied by reduced expression of wound healing and antifibrotic programs. Together, these findings identify SP1-dependent mechanosensing as a previously unrecognized pathway controlling human monocyte activation in the skin and provide mechanistic insight into how tissue stiffness sustains inflammation in SSc.
Related
- Hyperglycemia-induced placental inflammation involves differential activation of RAGE-associated PI3K/MAPK/NF-κB signaling pathways
- The Microbiota–Gut–Brain Axis in Obesity: Inflammation, Appetite Dysregulation, and Feeding Behavior
- DNA Sensors in Immune Dysregulation: Mechanisms, Crosstalk, and Therapeutic Implications of STING-Dependent and STING-Independent Signaling Pathways
- An Overview of the Crosstalk Dysregulation Between miRNAs and Signaling Pathways in Cancer: A Recent Perspective on Regulatory Networks
- Editorial: Lipid signaling in immunity: from inflammation and ageing to cancer and therapeutic opportunities
BibTeX
@article{chaudhary2026dysregulation,
title = {{Dysregulation of mechanosensing signaling in monocytes of patients with systemic sclerosis is associated with skin inflammation}},
author = {Vidyanath Chaudhary and Yong Du and Bikash Mishra and Marie Dominique Ah Kioon and Palak Ahuja and Lionel B. Ivashkiv and Marie-Elise Truchetet and Robert F. Spiera and Kimberly Lakin and Jessica K. Gordon and Franck J. Barrat},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
year = {2026},
month = nov,
doi = {10.1073/pnas.2609599123},
url = {https://doi.org/10.1073/pnas.2609599123},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Dysregulation of mechanosensing signaling in monocytes of patients with systemic sclerosis is associated with skin inflammation
AU - Vidyanath Chaudhary
AU - Yong Du
AU - Bikash Mishra
AU - Marie Dominique Ah Kioon
AU - Palak Ahuja
AU - Lionel B. Ivashkiv
AU - Marie-Elise Truchetet
AU - Robert F. Spiera
AU - Kimberly Lakin
AU - Jessica K. Gordon
AU - Franck J. Barrat
PY - 2026
DA - 2026/11/05
JO - Proceedings of the National Academy of Sciences of the United States of America
DO - 10.1073/pnas.2609599123
UR - https://doi.org/10.1073/pnas.2609599123
AB - Systemic sclerosis (SSc) is a severe autoimmune connective tissue disease characterized by immune dysregulation and progressive fibrosis of the skin and internal organs, resulting in substantial organ dysfunction and increased mortality. Fibrosis is driven in part by infiltration of immune cells, including monocytes that become activated within fibrotic tissue. However, how the mechanical properties of fibrotic skin regulate their function remains poorly understood. Here, we demonstrate that increased stiffness activates human monocytes through mechanosensing. Reanalysis of single cell RNA sequencing datasets revealed that skin infiltrating monocytes exhibit heightened inflammatory signatures as compared to circulating counterparts, with further amplification in SSc. Using collagen-coated hydrogels modeling physiological and fibrotic stiffness, we show that increased stiffness enhances CD86 expression, and broadly upregulates inflammatory transcriptional programs in human monocytes. Mechanistically, stiffness-driven activation was associated with chromatin remodeling and epigenetic reprogramming, identifying the transcription factor Specificity Protein 1 (SP1) as a central regulator. CRISPR–Cas9-mediated disruption or pharmacologic inhibition of SP1 significantly attenuated stiffness- induced inflammatory gene expression, whereas we found no evidence for involvement of the canonical YAP/TAZ–TEAD axis, and pharmacological modulation of PIEZO1 neither reproduced nor blocked the response. Further, monocytes from patients with SSc displayed altered transcriptional trajectories and an exaggerated inflammatory response to high stiffness, accompanied by reduced expression of wound healing and antifibrotic programs. Together, these findings identify SP1-dependent mechanosensing as a previously unrecognized pathway controlling human monocyte activation in the skin and provide mechanistic insight into how tissue stiffness sustains inflammation in SSc.
SN - 0027-8424
SN - 1091-6490
ER -